{"filing":{"accession_number":"0001279569-26-000733","cik":"0001847409","ticker":"HITI","company_name":"High Tide Inc.","form":"6-K","filing_date":"2026-08-04","report_date":"2026-08-04","primary_document":"hightide6k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1847409/000127956926000733/hightide6k.htm"},"events":[{"id":23577,"run_id":21314,"accession_number":"0001279569-26-000733","anchor_item_number":"EX-99.1","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.92,"summary":"This is a preliminary guidance announcement for Q3 2026 (quarter ended July 31, 2026) disclosing expected record revenue ($195.0–$200.0M), gross profit ($51.0–$53.5M), and Adjusted EBITDA ($15.2–$16.5M), all exceeding analyst consensus expectations. Although labeled \"guidance\" rather than final results, it functions as an earnings disclosure announcing anticipated quarterly financial performance ahead of the full results release on September 14, 2026. The guidance is material to investors as it signals significant year-over-year growth (30–34% revenue, 27–33% gross profit, 43–55% Adjusted EBITDA) and operational strength in both Canadian retail and German medical cannabis distribution.","company_name":"High Tide Inc.","ticker":"HITI","filing_date":"2026-08-04","form":"6-K","submitted_at":null,"items":[{"id":23848,"accession_number":"0001279569-26-000733","item_number":"EX-99.1","item_title":"ex991.htm","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.92,"reasoning":"This is a preliminary guidance announcement for Q3 2026 (quarter ended July 31, 2026) disclosing expected record revenue ($195.0–$200.0M), gross profit ($51.0–$53.5M), and Adjusted EBITDA ($15.2–$16.5M), all exceeding analyst consensus expectations. Although labeled \"guidance\" rather than final results, it functions as an earnings disclosure announcing anticipated quarterly financial performance ahead of the full results release on September 14, 2026. The guidance is material to investors as it signals significant year-over-year growth (30–34% revenue, 27–33% gross profit, 43–55% Adjusted EBITDA) and operational strength in both Canadian retail and German medical cannabis distribution.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-08-05T00:03:12.867930+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":23848,"accession_number":"0001279569-26-000733","item_number":"EX-99.1","item_title":"ex991.htm","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.92,"reasoning":"This is a preliminary guidance announcement for Q3 2026 (quarter ended July 31, 2026) disclosing expected record revenue ($195.0–$200.0M), gross profit ($51.0–$53.5M), and Adjusted EBITDA ($15.2–$16.5M), all exceeding analyst consensus expectations. Although labeled \"guidance\" rather than final results, it functions as an earnings disclosure announcing anticipated quarterly financial performance ahead of the full results release on September 14, 2026. The guidance is material to investors as it signals significant year-over-year growth (30–34% revenue, 27–33% gross profit, 43–55% Adjusted EBITDA) and operational strength in both Canadian retail and German medical cannabis distribution.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-08-05T00:03:12.867930+00:00","company_name":"High Tide Inc.","ticker":"HITI","filing_date":"2026-08-04"}]}